Culley Brian M (CIK 0001310683)

Latest company ownership

SVRA - Savara Inc
Role: CEO
Shares held
34,500
Last filed at
Mar 15, 2012
Confidence Score
50.0
2025Q4
Confidence Score History
2010Q2 2025Q4
Shares held
31,249
Last filed at
Feb 12, 2025
Confidence Score
74.5
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 19, 2025 Dec 19, 2025 Lineage Cell Therapeutics, Inc. CEO Sell 82.5 +8,591 4.02% ✗ $561.1
Feb 11, 2025 Feb 12, 2025 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -12,547 -5.55% ✗ $8.2K
Nov 21, 2024 Nov 22, 2024 Lineage Cell Therapeutics, Inc. CEO Buy 91.3 +40,000 25.83% ✗ $24K
May 24, 2024 May 28, 2024 Lineage Cell Therapeutics, Inc. CEO Buy 86.3 +10,000 6.90% ✗ $10.5K
Feb 11, 2024 Feb 12, 2024 Lineage Cell Therapeutics, Inc. CEO Sell 46.3 -12,806 -8.12% ✗ $13.8K
Feb 11, 2023 Feb 14, 2023 Lineage Cell Therapeutics, Inc. CEO Sell 46.3 -12,744 -9.16% ✗ $17.2K
Jun 30, 2022 Jun 30, 2022 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -4.72% ✗ $8.4K
Mar 31, 2022 Apr 4, 2022 Lineage Cell Therapeutics, Inc. CEO Buy 77.5 +1,057 1.09% ✗ $1.6K
Mar 25, 2022 Mar 28, 2022 Lineage Cell Therapeutics, Inc. CEO Buy 85.0 +5,250 6.91% ✗ $7.2K
Dec 31, 2021 Jan 3, 2022 Lineage Cell Therapeutics, Inc. CEO Sell 46.3 -5,343 -6.57% ✗ $13.1K
Sep 30, 2021 Oct 12, 2021 Lineage Cell Therapeutics, Inc. CEO Sell 46.3 -5,343 -7.50% ✗ $13.5K
Jun 28, 2021 Jun 30, 2021 Lineage Cell Therapeutics, Inc. CEO Sell 5.0 -455,343 -81.77% ✓ $1.3M
Mar 31, 2021 Apr 1, 2021 Lineage Cell Therapeutics, Inc. CEO Sell 46.3 -5,343 -2.66% ✗ $12.6K
Dec 31, 2020 Dec 31, 2020 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -2.80% ✗ $9.4K
Sep 30, 2020 Sep 30, 2020 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -2.95% ✗ $5K
Jun 30, 2020 Jul 2, 2020 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -3.13% ✗ $4.6K
Mar 31, 2020 Mar 31, 2020 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -3.33% ✗ $4.4K
Dec 31, 2019 Dec 31, 2019 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -3.55% ✗ $4.8K
Sep 30, 2019 Oct 1, 2019 Lineage Cell Therapeutics, Inc. CEO Sell 47.5 -5,343 -3.81% ✗ $5.2K
Sep 17, 2019 Sep 19, 2019 Lineage Cell Therapeutics, Inc. CEO Sell 46.3 -21,371 -14.60% ✗ $21.4K
Aug 13, 2019 Aug 15, 2019 Lineage Cell Therapeutics, Inc. CEO Buy 91.3 +10,000 13.42% ✗ $10.1K
Jan 1, 2019 Jan 3, 2019 Lineage Cell Therapeutics, Inc. CEO Sell 26.3 -40,880 -40.88% ✗ $37.3K
Mar 14, 2012 Mar 15, 2012 Savara Inc CEO Buy 91.3 +20,500 146.43% ✗ $12.1K
Mar 13, 2012 Mar 14, 2012 Savara Inc CEO Buy 90.0 +14,000 100.00% ✗ $8.1K
Jun 2, 2011 Jun 3, 2011 Savara Inc CEO Sell 13.8 -5,000 -100.00% ✓ $12.2K
May 27, 2010 May 27, 2010 Savara Inc CEO Buy 90.0 +5,000 100.00% ✗ $9.5K